Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has assisted Peab in connection with a transaction with SkiStar
Mandate

Vinge has assisted Peab in connection with a transaction with SkiStar

May 28, 2021 Capital Markets and Public M&A Real Estate and Construction

Vinge has assisted Peab in connection with a transaction with Skistar, whereby Peab and SkiStar deepen the collaboration on management and development of properties in the Scandinavian mountains.

Through the transaction, three jointly owned lodges in the Swedish and Norwegian mountainside locations are transferred to the same group structure and in addition, the joint ventures will acquire three new lodges in Hemsedal in Norway, Lindvallen in Sälen and Hundfjället in Sälen (under construction) and development rights for around 60,000 GFA in Sälen, Vemdalen, Åre and Duved. In addition, in connection with the transaction, SkiStar is to sign new leases on both the newly acquired properties and the previously jointly owned properties.

Vinge’s team consisted of Charlotte Levin, Assur Badur, Kristoffer Larson and Joel Magnusson.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025